Ignite Creation Date:
2025-12-24 @ 2:07 PM
Ignite Modification Date:
2025-12-27 @ 9:25 PM
Study NCT ID:
NCT01164995
Status:
COMPLETED
Last Update Posted:
2023-09-07
First Post:
2010-07-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study With Wee-1 Inhibitor AZD1775 (MK-1775) and Carboplatin to Treat p53 Mutated Refractory and Resistant Ovarian Cancer
Sponsor:
The Netherlands Cancer Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-07
Start Date Type:
None
Primary Completion Date:
2023-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-04
Completion Date Type:
ACTUAL
First Submit Date:
2010-07-09
First Submit QC Date:
None
Study First Post Date:
2010-07-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-08-31
Last Update Post Date:
2023-09-07
Last Update Post Date Type:
ACTUAL